Clinical Trials

Intec Pharma Ltd (NASDAQ:NTEC) stock price target has been raised by Oppenheimer to $15.00 from $10.00 while maintaining the Outperform rating. The analyst Jay Olson has noted that the shares are up 60% since June and expects further upside as Accordion resonates with investors. Further the analyst Olson noted the clinical and operational progress that […]

by

It may be one of the world’s oldest drugs, but cannabis has caught the world unprepared. After 80 years of draconian prohibition, the tide has suddenly turned. Medicinal cannabis is flooding in and overwhelming the medical establishment, as patients clamour for it, many convinced it is a harmless cure-all to their ills. Some 2.3 million […]

by

NEW YORK, September 19, 2017 /PRNewswire/ — The hazards of pharmacology have hardly changed since Paracelsus, a famous Renaissance physician, astoundingly declared that it was only the dosage that separated a medicine from a poison, bundled with adverse side effects. Despite considerable advances in medicine, many medications are still as injurious as their Renaissance precursors. […]

by

TORONTO, ONTARIO–(Marketwired – Sept. 19, 2017) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs, today announced that it has entered into a license agreement with South Carolina Research Foundation (“SCRF”), under which Revive will acquire […]

by

Medicine bottle image: monicore A small observational trial of the use of medicinal cannabis extracts in treating autism has returned positive results. Australia’s Zelda Therapeutics sponsored a trial in Chile involving 21 patients, who were treated over at least three months. According to the company, results of the trial indicate cannabis extracts are more effective […]

by

TORONTO, ONTARIO–(Marketwired – Sept. 19, 2017) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs, today announced that it has entered into a license agreement with South Carolina Research Foundation (“SCRF”), under which Revive will acquire […]

by

NEW YORK, September 19, 2017 /PRNewswire/ — The hazards of pharmacology have hardly changed since Paracelsus, a famous Renaissance physician, astoundingly declared that it was only the dosage that separated a medicine from a poison, bundled with adverse side effects. Despite considerable advances in medicine, many medications are still as injurious as their Renaissance precursors. […]

by

Whole-plant marijuana and its products are already used during palliative care outside of the traditional hospice and hospital settings. Santa Cruz, California, is home to the Wo/Men’s Alliance for Medical Marijuana, a cannabis collective that has been compared to a traditional hospice. Director Valerie Corral helped pass the country’s first medical cannabis law in part […]

by

A phase 2 trial of Zynerba Pharmaceuticals’ transdermal cannabinoid candidate has missed all its endpoints. The failure of the study to hit a single goal or show a dose response raises big doubts about the drug’s prospects—and wiped more than 55% off Zynerba’s stock price. Investigators enrolled 188 adults with refractory epilepsy with focal seizures and […]

by

August 24, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks releases a snapshot of companies in the cannabis/marijuana sector that are developing methods for cannabinoids to be used as medicine and treatments for cancer, epilepsy, concussions and traumatic brain injury. The Hemp Business Journal projects that the […]

by

What CBDs (Cannabidiols) Are Currently In Clinical Trials And What Results Are They Proving As CBD (cannabidiol) comes into the light of the public eye, the curiosity of government researchers continues to grow. Through this growth of interest comes with it funding for real science and research into the mysteries of cannabis sativa and specifically, […]

by

By Veterinary Practice News Editors The AKC Canine Health Foundation (CHF), which has funded more than $2 million for canine epilepsy research, launched an initiative in 2017 to further understand the most common neurological disorder that affects pure- and mixed-breed dogs. Improved treatments are urgently needed, especially for dogs with drug-resistant epilepsy or where side […]

by

NEW YORK, September 13, 2017 /PRNewswire/ — The upward trajectory of the cannabis industry has garnered comparisons to the Internet boom of the early 2000s, as North American sales are on pace to record a compound annual growth rate of 25 percent through 2021, according to Arcview Market Research (1). These comparisons are certainly attention-grabbing, […]

by